Citations 2
PB2111: SUBGROUP ANALYSIS IN RE-MIND2, AN OBSERVATIONAL, RETROSPECTIVE COHORT STUDY OF TAFASITAMAB + LENALIDOMIDE VERSUS SYSTEMIC THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Nowakowski, Grzegorz S. , Yoon, Dok Hyun , Joffe, E., Sabatelli, L., Waltl, Eva E., Alvero, Carmelita, Hess, G., Kim, K. , Salles, G., Joffe, Erel , Zinzani, Pier Luigi , Sabatelli, Lorenzo , Hess, G., Riedell, Peter A. , Kim, K., Brixner, Diana I , Salles, G.
HemaSphere | June 24, 2022 | Volume: 6 | Issue: No issue available | Pages: 1982-1983
P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Joffe, E., Nowakowski, Grzegorz S. , Lunning, Matthew A. , Ramchandren, Radhakrishnan , Li, C.-C., Zhou, Li , Martinez, Elizabeth , Roemeling, R. von, Earhart, Robert H., McMahon, Meaghan, Isufi, Iris, Leslie, Lori A. , Joffe, Erel , Tun, Han W. , Rosenthal, Allison
HemaSphere | June 23, 2022 | Volume: 6 | Issue: No issue available | Pages: 1011-1012